This inventor holds 3 USPTO granted patents. Top assignees: Joslin Diabetes Center, Inc., Other. Active years: 1999-2005.
Company Filing History:
2 out of 76 
1 out of 834,411 Years Active: 1999-2005
Title: Massimo Pietropaolo: Innovator in Diabetes Research
Introduction
Massimo Pietropaolo is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of diabetes research, particularly in understanding the mechanisms associated with Type 1 Diabetes Mellitus. With a total of 3 patents, his work has implications for early detection and potential treatment of this chronic condition.
Latest Patents
Pietropaolo's latest patents focus on a 69 kD protein, designated PM-1, which is expressed in human pancreatic islet cells and a human insulinoma. The amino acid sequence of this protein has been determined, and autoantibodies to the PM-1 protein have been found in the sera of prediabetic patients. Natural, synthetic, or recombinant forms of the PM-1 protein can be utilized in immunochemical assays to detect anti-PM-1 autoantibodies. This innovation aids in identifying patients at risk of developing diabetes.
Career Highlights
Throughout his career, Pietropaolo has worked with esteemed organizations, including the Joslin Diabetes Center, Inc. His research has been pivotal in advancing the understanding of diabetes and its associated biomarkers.
Collaborations
One of his notable collaborators is George S. Eisenbarth, with whom he has worked on various projects related to diabetes research.
Conclusion
Massimo Pietropaolo's contributions to diabetes research through his patents and collaborations highlight his role as an innovator in the field. His work continues to pave the way for advancements in the detection and understanding of Type 1 Diabetes Mellitus.